PHARMA IN RUSSIA: CHALLENGES, EVALUATION, PROSPECTS
The development of the modern pharmaceutical market of the Russian Federation deserves special attention. Government regulation covers this segment significantly. At the same time, the pharma is changing in unison with the market digitization. To fully assess this aspect of development, it is necessary to assess trends and development prospects. The object of our research was the pharmaceutical market. This article analyzes the trends and challenges of the pharmaceutical market of the Russian Federation. Based on the statistical data of industry companies, this article describes the characteristics of the market from the point of view of the main players. The first Russian brand, the first foreign brand, the first producer of wound care and first aid products, the first Russian company selling prescription drugs in the retail market, the first Russian company selling non-prescription drugs in the retail market, the first Russian company selling medicines in the state segment, the first foreign manufacturer, the first manufacturer of blood pressure monitors, the first brand of cosmetics, the first manufacturer of biologically active additives. The article also presents the results of analysis of the dynamics of sales of medicines, commodity turnover of the additional pharmacy assortment product segment, concomitant medicines and medical products intended for the prevention, treatment of diseases, alleviation of the human condition, care of body parts. The authors outline the prospects for changes in the pharmaceutical market in modern economic conditions.